Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036098
Filing Date
2024-08-08
Accepted
2024-08-08 16:00:13
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20240630.htm   iXBRL 10-Q 825009
2 EX-31.1 crdf-063024exhibit311.htm EX-31.1 10716
3 EX-31.2 crdf-063024exhibit312.htm EX-31.2 10686
4 EX-32.1 crdf-063024exhibit321.htm EX-32.1 6119
5 EX-32.2 crdf-063024exhibit322.htm EX-32.2 6089
  Complete submission text file 0001628280-24-036098.txt   4326908

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240630.xsd EX-101.SCH 24680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20240630_cal.xml EX-101.CAL 56999
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20240630_def.xml EX-101.DEF 118151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240630_lab.xml EX-101.LAB 353665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240630_pre.xml EX-101.PRE 234546
54 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240630_htm.xml XML 623773
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 241188002
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)